Double-Dose chemo strategy shows promise against pancreatic cancer

NCT ID NCT02047474

Completed Disease control Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a combination of chemotherapy drugs given both before and after surgery for people with early-stage pancreatic cancer. The goal was to shrink the tumor before surgery and kill any remaining cancer cells afterward. 46 participants were enrolled to see if this approach could improve how long they lived without the cancer growing back.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACINAR CELL ADENOCARCINOMA OF THE PANCREAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic acinar cell carcinoma pancreatic adenocarcinoma pancreatic ductal adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACINAR CELL ADENOCARCINOMA OF THE PANCREAS DUCT CELL ADENOCARCINOMA OF THE PANCREAS STAGE I PANCREATIC CANCER STAGE IIA PANCREATIC CANCER STAGE IIB PANCREATIC CANCER

Contacts and locations

Locations

Smilow Cancer Hospital at Fairfield

Fairfield, Connecticut, 06824, United States
Smilow Cancer Hospital at Guilford

Guilford, Connecticut, 06437, United States
Smilow Cancer Hospital at North Haven

North Haven, Connecticut, 06473, United States
Smilow Cancer Hospital at Orange

Orange, Connecticut, 06477, United States
Smilow Cancer Hospital at St. Francis Hospital

Hartford, Connecticut, 06105, United States
Smilow Cancer Hospital at Torrington

Torrington, Connecticut, 06790, United States
Smilow Cancer Hospital at Trumbull

Trumbull, Connecticut, 06611, United States
Smilow Cancer Hospital at Waterbury

Waterbury, Connecticut, 06708, United States
Yale University

New Haven, Connecticut, 06520-8032, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.